Filing Details
- Accession Number:
- 0000014272-17-000203
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-05 18:15:41
- Reporting Period:
- 2017-12-04
- Accepted Time:
- 2017-12-05 18:15:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1199294 | Sandra Leung | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Evp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Acquisiton | 2017-12-04 | 156,582 | $22.14 | 584,373 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2017-12-04 | 156,582 | $63.37 | 427,791 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2017-12-04 | 156,582 | $0.00 | 156,582 | $22.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-03-03 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.10 Par Value | 5,974 | Indirect | By BMY Savings and Investment Program |
Footnotes
- A portion of these shares were sold to cover exercise price and taxes in accordance with broker's procedure for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $63.01 to $63.62, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Based on a plan statement as of the end of the most recent fiscal quarter
- All of the shares are currently exercisable.
Billionaire Hedge Funds
